期刊文献+

探寻我国仿制药的发展策略 被引量:6

Explore the Development of Native Generic Drugs
暂未订购
导出
摘要 目的提升我国医药产业的国际竞争力,推动新医改顺利进行。方法通过比较国内外仿制药的发展现状,分析国内发展的不足,探讨解决办法。结果与结论根据我国所具备的特有条件和特殊国情,发展仿制药是大势所趋。从参与国际相关标准的制定、知识产权、政府扶持、人才培养等方面入手,探讨促进我国仿制药发展的策略。 Objective Promoting Chinese international competitiveness,propel the new reform of medical system to go on smoothly.Methods By comparing the development of generic drug between Chinese and foreign,find deficiencies in China,and give suggestions based on the specific conditions in our country.Results and Conclusion According to the specific factors and conditions in China,it is an irresistible trend to develop generic drugs,explore the strategies on setting international relative standards,intellectual property,government support,talent training.Moreover,generic drugs is special product,we need the international co-operation to develop it.
出处 《中国药事》 CAS 2011年第5期427-429,共3页 Chinese Pharmaceutical Affairs
关键词 仿制药 必要性 策略 generic drug necessity strategy
  • 相关文献

参考文献15

二级参考文献6

  • 1Alan DL.Patent term restoration[J] .Patent and Trademark, 1984,12(6) : 533.
  • 2Alison Y, Meredith SA. Pharmaceutical pricing and Hatch - Waxman reform:the right prescription [ J ] .Gen Med ,2004,17(1) :228.
  • 3Laura R.Analysis of recent proposals to reconfigure Hatch - Waxman[J ]. Intell Prop L, 2003,15(11) : 47.
  • 4Sarah EE.Hatch - Waxman reform and accelerated market entry of generic drug: is faster necessarily better[J] .Duke L & Tech Rev ,2003,22(16) :18.
  • 5Generic Drug Approvals[EB/OL].[2006-01-05].http://www.fda.gov.
  • 6基础数据库查询[EB/OL].[2006-08-20].http://appl.sfda.gov.cn.

共引文献47

同被引文献56

引证文献6

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部